Real‐world non‐interventional long‐term post‐authorisation safety study of ruxolitinib in myelofibrosisFiorenza Barraco, Heinz Gisslinger, Andreas Reiter et al.|British Journal of Haematology|2020Cited by 30
PF679 REAL‐WORLD SAFETY DATA FROM A NONINTERVENTIONAL LONG‐TERM POSTAUTHORIZATION SAFETY STUDY OF RUXOLITINIB IN MYELOFIBROSISFiorenza Barraco, Heinz Gisslinger, Richard Greil et al.|HemaSphere|2019Cited by 0